Great Point Partners LLC Ultragenyx Pharmaceutical Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$31.73 - $49.19 $2.52 Million - $3.91 Million
-79,426 Reduced 10.92%
648,000 $31 Million
Q3 2023

Nov 14, 2023
BUY
$34.92 - $46.66 $1.75 Million - $2.33 Million
50,000 Added 7.38%
727,426 $25.9 Million
Q1 2023

May 15, 2023
BUY
$36.99 - $48.71 $12.4 Million - $16.3 Million
335,126 Added 97.9%
677,426 $27.2 Million
Q4 2022

Feb 14, 2023
BUY
$33.72 - $46.33 $11.5 Million - $15.9 Million
342,300 New
342,300 $15.9 Million

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.5M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.01B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email